Literature DB >> 18574154

Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis.

Leo A B Joosten1, Bas Heinhuis, Shahla Abdollahi-Roodsaz, Gerben Ferwerda, Lionel Lebourhis, Dana J Philpott, Marie-Anne Nahori, Calin Popa, Servaas A Morre, Jos W M van der Meer, Stephen E Girardin, Mihai G Netea, Wim B van den Berg.   

Abstract

The pathogenesis of chronic joint inflammation remains unclear, although the involvement of pathogen recognition receptors has been suggested recently. In the present article, we describe the role of two members of the NACHT-LRR (NLR) family, Nod1 (nucleotide-binding oligomerization domain) and Nod2 in a model of acute joint inflammation induced by intraarticular injection of Streptococcus pyogenes cell wall fragments. Here, we show that Nod2 deficiency resulted in reduced joint inflammation and protection against early cartilage damage. In contrast, Nod1 gene-deficient mice developed enhanced joint inflammation with concomitant elevated levels of proinflammatory cytokines and cartilage damage, consistent with a model in which Nod1 controls the inflammatory reaction. To explore whether the different function of Nod1 and Nod2 occurs also in humans, we exposed peripheral blood mononuclear cells (PBMCs) carrying either Nod1ins/del or Nod2fs mutation with SCW fragments in vitro. Production of both TNFalpha and IL-1beta was clearly impaired in PBMCs carrying the Nod2fs compared with PBMCs isolated from healthy controls. In line with results in Nod1 gene-deficient mice, PBMCs from individuals bearing a newly described Nod1 mutation produced enhanced levels of proinflammatory cytokines after 24-h stimulation with SCW fragments. These data indicate that the NLR family members Nod1 and Nod2 have different functions in controlling inflammation, and that intracellular Nod1-Nod2 interactions may determine the severity of arthritis in this experimental model. Whether a distorted balance between the function of Nod1 and/or Nod2 is involved in the pathogenesis of human autoinflammatory or autoimmune disease, such as rheumatoid arthritis, remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18574154      PMCID: PMC2449357          DOI: 10.1073/pnas.0710445105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

2.  Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.

Authors:  Mihai G Netea; Gerben Ferwerda; Dirk J de Jong; Trees Jansen; Liesbeth Jacobs; Matthijs Kramer; Ton H J Naber; Joost P H Drenth; Stephen E Girardin; Bart Jan Kullberg; Gosse J Adema; Jos W M Van der Meer
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

3.  Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.

Authors:  Leo A B Joosten; Timothy R D Radstake; Erik Lubberts; Liduine A M van den Bersselaar; Piet L C M van Riel; Peter L E M van Lent; Pilar Barrera; Wim B van den Berg
Journal:  Arthritis Rheum       Date:  2003-02

4.  NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.

Authors:  Tomohiro Watanabe; Atsushi Kitani; Peter J Murray; Warren Strober
Journal:  Nat Immunol       Date:  2004-06-27       Impact factor: 25.606

5.  Detection of muramic acid in a carbohydrate fraction of human spleen.

Authors:  M A Hoijer; M J Melief; C G van Helden-Meeuwsen; F Eulderink; M P Hazenberg
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

Review 6.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

7.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

8.  NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.

Authors:  Mihai G Netea; Bart Jan Kullberg; Dirk J de Jong; Barbara Franke; Tom Sprong; Ton H J Naber; Joost P H Drenth; Jos W M Van der Meer
Journal:  Eur J Immunol       Date:  2004-07       Impact factor: 5.532

9.  NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis.

Authors:  Gerben Ferwerda; Stephen E Girardin; Bart-Jan Kullberg; Lionel Le Bourhis; Dirk J de Jong; Dennis M L Langenberg; Reinout van Crevel; Gosse J Adema; Tom H M Ottenhoff; Jos W M Van der Meer; Mihai G Netea
Journal:  PLoS Pathog       Date:  2005-11-25       Impact factor: 6.823

10.  Arthritis in rats after systemic injection of streptococcal cells or cell walls.

Authors:  W J Cromartie; J G Craddock; J H Schwab; S K Anderle; C H Yang
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  28 in total

1.  Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism.

Authors:  Marije Oosting; Frank L van de Veerdonk; Thirumala-Devi Kanneganti; Patrick Sturm; Ineke Verschueren; Anneleen Berende; Jos W M van der Meer; Bart-Jan Kullberg; Mihai G Netea; Leo A B Joosten
Journal:  Eur J Immunol       Date:  2010-12-09       Impact factor: 5.532

2.  PGLYRP-2 and Nod2 are both required for peptidoglycan-induced arthritis and local inflammation.

Authors:  Sukumar Saha; Jin Qi; Shiyong Wang; Minhui Wang; Xinna Li; Yun-Gi Kim; Gabriel Núñez; Dipika Gupta; Roman Dziarski
Journal:  Cell Host Microbe       Date:  2009-02-19       Impact factor: 21.023

Review 3.  NOD proteins: regulators of inflammation in health and disease.

Authors:  Dana J Philpott; Matthew T Sorbara; Susan J Robertson; Kenneth Croitoru; Stephen E Girardin
Journal:  Nat Rev Immunol       Date:  2013-12-13       Impact factor: 53.106

4.  Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis.

Authors:  Ruth J Napier; Ellen J Lee; Emily E Vance; Paige E Snow; Kimberly A Samson; Clare E Dawson; Amy E Moran; Peter Stenzel; Michael P Davey; Shimon Sakaguchi; Holly L Rosenzweig
Journal:  J Immunol       Date:  2018-08-27       Impact factor: 5.422

5.  Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity.

Authors:  Patrick J Shaw; Maggie J Barr; John R Lukens; Maureen A McGargill; Hongbo Chi; Tak W Mak; Thirumala-Devi Kanneganti
Journal:  Immunity       Date:  2011-01-13       Impact factor: 31.745

Review 6.  RIP2 activity in inflammatory disease and implications for novel therapeutics.

Authors:  Janice C Jun; Fabio Cominelli; Derek W Abbott
Journal:  J Leukoc Biol       Date:  2013-06-21       Impact factor: 4.962

7.  NOD1 expression in the eye and functional contribution to IL-1beta-dependent ocular inflammation in mice.

Authors:  Holly L Rosenzweig; Kellen T Galster; Stephen R Planck; James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-13       Impact factor: 4.799

Review 8.  NOD-like receptors and inflammation.

Authors:  Rebeccah J Mathews; Michael B Sprakes; Michael F McDermott
Journal:  Arthritis Res Ther       Date:  2008-11-25       Impact factor: 5.156

9.  Dana Philpott: Exploring the land of NOD. Interview by Kira Heller.

Authors:  Dana Philpott
Journal:  J Exp Med       Date:  2009-04-13       Impact factor: 14.307

Review 10.  Toll-like receptors and NOD-like receptors in rheumatic diseases.

Authors:  William J McCormack; Andrew E Parker; Luke A O'Neill
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.